About the Authors

Kensuke Nomura

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

Affiliation Department of Child Psychiatry, Shimada Ryoiku Medical Center for Challenged Children, Tokyo, Japan

Ryosuke Tarumi

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

Affiliations Department of Child Psychiatry, Shimada Ryoiku Medical Center for Challenged Children, Tokyo, Japan, Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan

Kazunari Yoshida

Roles Data curation, Formal analysis, Writing – original draft, Writing – review & editing

Affiliations Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, Pharmacogenetics Research Clinic, Centre for Addiction and Mental Health, Toronto, Ontario, Canada, Azrieli Adult Neurodevelopmental Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada

Mitsuhiro Sado

Roles Conceptualization, Formal analysis, Methodology, Supervision, Writing – review & editing

Affiliation Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan

Takefumi Suzuki

Roles Conceptualization, Formal analysis, Supervision, Writing – review & editing

Affiliations Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, Department of Neuropsychiatry, University of Yamanashi Faculty of Medicine, Yamanashi, Japan

Masaru Mimura

Roles Conceptualization, Methodology, Supervision, Writing – review & editing

Affiliation Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan

Hiroyuki Uchida

Roles Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing – original draft, Writing – review & editing

hiroyuki_uchida@keio.jp

Affiliation Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan

Competing Interests

KN has received honoraria (lecture fees) from Janssen Pharmaceutical, Eli Lilly, Shire, and Shionogi within the past three years. RT declares no conflicts of interest associated with this manuscript. KY has received honoraria (manuscript fees) from Sumitomo Dainippon Pharma, fellowship grants from the Japan Research Foundation for Clinical Pharmacology and Azrieli Adult Neurodevelopmental Centre Postdoctoral Fellowship at CAMH, and consultant fees from Signant Health and VeraSci within the past three years. MS has received honoraria (lecture fees) from Meiji Seika Pharma, Shionogi, Kumon Institute of Education, and Mochida Pharma within the past three years. TS has received manuscript or speaker fees from Astellas, Dainippon Sumitomo Pharma, Eisai, Eli Lilly, Elsevier Japan, Janssen Pharmaceuticals, Kyowa Yakuhin, Meiji Seika Pharma, Mitsubishi Tanabe Pharma, MSD, Novartis, Otsuka Pharmaceutical, Shionogi, Shire, Tsumura, Wiley Japan, and Yoshitomi Yakuhin, and research grants from Eisai, Mochida Pharmaceutical, Meiji Seika Pharma, and Shionogi within the past three years. MM has received speaker’s honoraria from Byer Pharmaceutical, Daiichi Sankyo, Dainippon-Sumitomo Pharma, Eisai, Eli Lilly, Fuji Film RI Pharma, Hisamitsu Pharmaceutical, Janssen Pharmaceutical, Kyowa Pharmaceutical, Mochida Pharmaceutical, MSD, Mylan EPD, Nihon Medi-physics, Nippon Chemipher, Novartis Pharma, Ono Yakuhin, Otsuka Pharmaceutical, Pfizer, Santen Pharmaceutical, Shire Japan, Takeda Yakuhin, Tsumura, and Yoshitomi Yakuhin within the past three years. Also, he received grants from Daiichi Sankyo, Eisai, Pfizer, Shionogi, Takeda, Tanabe Mitsubishi and Tsumura within the past three years outside the submitted work. HU has received grants from Eisai, Otsuka Pharmaceutical, Dainippon-Sumitomo Pharma, and Meiji-Seika Pharma, speaker’s honoraria from Otsuka Pharmaceutical, Dainippon-Sumitomo Pharma, Eisai, and Meiji-Seika Pharma, and advisory panel payments from Dainippon-Sumitomo Pharma within the past three years. This does not alter our adherence to PLOS ONE policies on sharing data and materials.